Genoks Teknoloji is a Turkey-based biotechnology and life sciences company that was founded in 2008. The company focuses on molecular biology and genetic research, with a particular emphasis on developing PCR and RTPCR-based diagnostic kits as well as DNA isolation kits. Over the years, Genoks has made significant investments, culminating in a 1,100 m² laboratory and office space and a team of over 70 experts in the field. They have also been actively engaged in sharing their technology with 10 countries, 500+ hospitals, and approximately 3000 physicians.
Genoks has conducted over 80,000 NGS tests and boasts advanced sequencing platforms, local servers, and a database of over 400,000 Gb NGS data. The company has made significant contributions to human health, not only in Turkey but also in the broader EEMEA region, with ambitions to become one of the largest genome centers in the region.
The company has also been instrumental in introducing Next Generation Sequencing technologies to Turkey, especially in their routine evaluation of genetic diseases. Genoks offers a wide range of genetic testing services, including Non-Invasive Prenatal Screening Tests, Whole Genome Sequencing, Whole Exome Sequencing, Cancer Genetics, Genetic Carrier Screening, Newborn Genetic Screening, and various others in the field of genetics.
There is no investment information
No recent news or press coverage available for Genoks Genetik Hastalıklar Değerlendirme Merkezi.
No funding or investment information available for Genoks Genetik Hastalıklar Değerlendirme Merkezi at this time.